Tip: Read this article for about 3 minutes!
Singapore The new crown epidemic-related expenditure in the past two fiscal years has reached 72.3 billion yuan.
Of the 72.3 billion yuan, 13.4 billion yuan is used for public health expenditures, 50.6 billion yuan is used to support employees and enterprises, and 8.3 billion yuan is used to assist families and society.
These expenditures are lower than the 100 billion yuan promised previously, and various government departments are also auditing the procurement and expenditures related to COVID-19 to ensure there are no wrong payments.
(Picture: Source from the Internet)
In addition, the Ministry of Finance of Singapore is also reviewing guidelines on procurement, contract management and payment to ensure that the measures are applicable to possible emergencies in the future.
Singapore Health Minister Wang Yikang said that Singapore will introduce a "bivalent vaccine" (bivalent) that can fight the original new crown and the Omickron variant strain at the same time.
will continue to update the vaccines for the national vaccination plan, and more details will be announced after confirmation.
The Ministry of Health currently has no intention to include new crown vaccine in the national child immunization program. Because the epidemic is still changing, the expert team will continue to pay attention to the new data and make suggestions, and the authorities will review it at appropriate times.
(Picture: Source from the Internet)
As of the 29th of last month, 5.7 people under the age of 18 who have completed vaccination have multisystem inflammation syndrome, while 38 of the peers who have not completed vaccination have been reported.
When lawmakers asked whether the authorities would consider getting Novavax vaccine for young people under the age of 18, Wang Yikang said that the Health Sciences Bureau and the group of vaccine experts are independently evaluating whether the vaccine is suitable for teenagers aged 12 to 17.
Novavax has not submitted an application to allow children under 12 to receive this vaccine.
There is currently no evidence that the new crown vaccine poses a potential risk to the developmental defects of children.
(Picture: Source from the Internet)
